From the Departments of Oncology/Hematology and
Pediatrics and.
J Biol Chem. 2014 Nov 7;289(45):31053-65. doi: 10.1074/jbc.M114.568287. Epub 2014 Sep 18.
Internal tandem duplication mutations in the Flt3 gene (ITD-FLT3) enhance cell migration toward the chemokine Cxcl12, which is highly expressed in the therapy-protective bone marrow niche, providing a potential mechanism underlying the poor prognosis of ITD-FLT3(+) acute myeloid leukemia. We aimed to investigate the mechanisms linking ITD-FLT3 to increased cell migration toward Cxcl12. Classification of the expression of Cxcl12-regulated genes in ITD-FLT3(+) cells demonstrated that the enhanced migration of ITD-FLT3(+) cells toward Cxcl12 was associated with the differential expression of genes downstream of Cxcl12/Cxcr4, which are functionally distinct from those expressed in ITD-FLT3(-) cells but are independent of the Cxcr4 expression levels. Among these differentially regulated genes, the expression of Rock1 in the ITD-FLT3(+) cells that migrated toward Cxcl12 was significantly higher than in ITD-FLT3(-) cells that migrated toward Cxcl12. In ITD-FLT3(-) cells, Rock1 expression and Mypt1 phosphorylation were transiently up-regulated but were subsequently down-regulated by Cxcl12. In contrast, the presence of ITD-FLT3 blocked the Cxcl12-induced down-regulation of Rock1 and early Mypt1 dephosphorylation. Likewise, the FLT3 ligand counteracted the Cxcl12-induced down-regulation of Rock1 in ITD-FLT3(-) cells, which coincided with enhanced cell migration toward Cxcl12. Rock1 antagonists or Rock1 shRNA abolished the enhanced migration of ITD-FLT3(+) cells toward Cxcl12. Our findings demonstrate that ITD-FLT3 increases cell migration toward Cxcl12 by antagonizing the down-regulation of Rock1 expression. These findings suggest that the aberrant modulation of Rock1 expression and activity induced by ITD-FLT3 may enhance acute myeloid leukemia cell chemotaxis to the therapy-protective bone marrow niche, where Cxcl12 is abundantly expressed.
Flt3 基因内串联重复突变(ITD-FLT3)增强了细胞向趋化因子 Cxcl12 的迁移能力,Cxcl12 在具有治疗保护作用的骨髓龛中高度表达,为 ITD-FLT3(+)急性髓系白血病不良预后提供了潜在机制。我们旨在研究将 ITD-FLT3 与趋化因子 Cxcl12 诱导的细胞迁移增加联系起来的机制。对 ITD-FLT3(+)细胞中 Cxcl12 调节基因的表达进行分类,表明 ITD-FLT3(+)细胞向 Cxcl12 的迁移增强与 Cxcl12/Cxcr4 下游基因的差异表达有关,这些基因的功能与 ITD-FLT3(-)细胞表达的基因不同,但独立于 Cxcr4 表达水平。在这些差异调节的基因中,向 Cxcl12 迁移的 ITD-FLT3(+)细胞中 Rock1 的表达明显高于向 Cxcl12 迁移的 ITD-FLT3(-)细胞。在 ITD-FLT3(-)细胞中,Rock1 表达和 Mypt1 磷酸化短暂上调,但随后被 Cxcl12 下调。相比之下,ITD-FLT3 的存在阻止了 Cxcl12 诱导的 Rock1 下调和早期 Mypt1 去磷酸化。同样,FLT3 配体抵消了 ITD-FLT3(-)细胞中 Cxcl12 诱导的 Rock1 下调,同时增强了向 Cxcl12 的细胞迁移。Rock1 拮抗剂或 Rock1 shRNA 消除了 ITD-FLT3(+)细胞向 Cxcl12 的增强迁移。我们的研究结果表明,ITD-FLT3 通过拮抗 Rock1 表达的下调增加了细胞向 Cxcl12 的迁移。这些发现表明,ITD-FLT3 引起的 Rock1 表达和活性的异常调节可能增强急性髓系白血病细胞向富含 Cxcl12 的治疗保护骨髓龛的趋化作用。